Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 13 BEAM 15 Best ARK Stocks To Buy Now
May 13 BOLD Boundless Bio GAAP EPS of -$12.27 misses by $11.54
May 13 BOLD Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 13 MGTX Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
May 12 TNYA 13 Penny Stocks with Insider Buying in 2024
May 11 NKTX Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans
May 10 MGTX MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
May 10 NKTX Nkarta Inc (NKTX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Analysis
May 10 MGTX MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)
May 10 NGNE Neurogene GAAP EPS of -$1.00 beats by $0.03
May 10 NGNE Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
May 9 NKTX Nkarta GAAP EPS of -$0.58 misses by $0.02
May 9 NKTX Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
May 9 MGTX MeiraGTx GAAP EPS of -$0.32, revenue of $0.69M
May 9 LXEO Lexeo Therapeutics reports Q1 results
May 9 MGTX MeiraGTx Reports First Quarter 2024 Financial and Operational Results
May 9 LXEO Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
May 9 BEAM Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 8 TSVT 2seventy bio, Inc. (TSVT) Q1 2024 Earnings Call Transcript
May 8 BEAM Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags